Skip to main content

Sara Escalera Anzola

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Sara Escalera Anzola

Institutions of which they are part

Predoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

Related professionals

Irene Hernández Hernández

Irene Hernández Hernández

Predoctoral researcher
Diabetes and Metabolism
Read more
Susana Núñez Pereira

Susana Núñez Pereira

Main researcher
Spine Research Unit
Read more
Leire Sanchez Corujo

Leire Sanchez Corujo

Predoctoral researcher
General Surgery
Read more
Carmen Roncal Mancho

Carmen Roncal Mancho

Postdoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.